Security key
10806X102
BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (the "Shares") (BBIO)
CUSIP: 10806X102
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock, par value $0.001 per share (the "Shares")
- Total 13F shares
- 145,248,661
- Total 13F value
- $1,443,911,522
- Share change
- +4,874,203
- Put/Call ratio
- 90%
- SEC-reported price per share
- $9.94
- Number of holders
- 170
- Value change
- +$48,733,339
- Number of buys
- 93
- Number of sells
- 57
- Shares outstanding
- 195,328,418
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
170
Top holders
10
BBIO full security history
Ownership snapshot
Full 13F holder table
BridgeBio Pharma, Inc. SEC filings
BridgeBio Pharma, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Kohlberg Kravis Roberts &...
Disclosed value leader
Kohlberg Kravis Roberts &...
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 16%
Showing 1-6 of 15 holder rows.
Quick read
Kohlberg Kravis Roberts & Co. L.P. leads the comparable SEC ownership view at 16%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Kohlberg Kravis Roberts & Co. L.P.'s linked filing trail.
Comparable ownership
Top 5
Kohlberg Kravis Roberts & Co. L.P.
16%
VIKING GLOBAL INVESTORS LP
14%
STATE STREET CORP
5.6%
VANGUARD GROUP INC
5.1%
BlackRock Finance, Inc.
4.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. |
13F
Company
|
16%
|
$282,034,000
31,060,971 shares
|
— | 30 Jun 2022 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
14%
|
$241,719,000
26,620,991 shares
|
— | 30 Jun 2022 |
| STATE STREET CORP |
13F
Company
|
5.6%
|
$99,490,000
10,957,063 shares
|
— | 30 Jun 2022 |
| VANGUARD GROUP INC |
13F
Company
|
5.1%
|
$89,851,000
9,895,537 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
4.8%
|
$84,976,000
9,358,581 shares
|
— | 30 Jun 2022 |
| Aisling Capital Management LP |
13F
Company
|
3.1%
|
$55,099,000
6,068,125 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
170
Shares
145,248,661
Rows available
170
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
153
Q3 2022 holders
170
Holder diff
17
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|